Organisational unit: School
Cellular and Molecular Medicine (CMM) is an internationally recognised centre of excellence for the study of cancer biology, infection and immunology and stem cell biology.
Academics from across the school’s various areas of expertise have been involved in studies that have significantly improved our scientific understanding of human disease and facilitated the development of best practice in the clinical environment.
We pride ourselves on how our researchers and students contribute to a growing portfolio of research that demonstrates how the University is at the forefront of efforts to turn science into medicine. Turning science into medicine is our core research mission, and to achieve this ambitious aim we undertake the fundamental science needed to progress ideas through to clinical trials or commercial development. The School has a proven track record for clinical translational work with five world leading 4* 'Impact Cases' in the REF2014.
We also aim to exploit our research discoveries through patent protection and by the formation of spin-out companies. Several spin-out companies have already been established to develop immunomodulatory molecules for autoimmune diseases, stem cells for the prevention of osteoarthritis and provide platform technologies for drug efficacy trials in immune diseases.
Research within the School of Cellular and Molecular Medicine is focused on three strategic research themes: